TY - JOUR
T1 - Combination Pills for Treatment of High Blood Pressure: Cost-effectiveness in The Asia Pacific Region
AU - Atkins, Emily R.
AU - Lung, Thomas
AU - Redfern, Julie
PY - 2017/4/1
Y1 - 2017/4/1
N2 - High blood pressure (BP) is the leading cause of preventable disease and death globally. Treatment of high BP substantially reduces major cardiovascular events, a 10 mmHg reduction in systolic BP (SBP) reduces the relative risk of coronary events by 22% and stroke by 41%. The World Health Organization estimates the global prevalence of high BP is 22% in adults, and prevalence is highest in low and middle income countries. Much of the global burden of high BP occurs in the Asia Pacific region, where almost 60% of the world's population reside; and, where affordability of treatment is vital to implementation.
AB - High blood pressure (BP) is the leading cause of preventable disease and death globally. Treatment of high BP substantially reduces major cardiovascular events, a 10 mmHg reduction in systolic BP (SBP) reduces the relative risk of coronary events by 22% and stroke by 41%. The World Health Organization estimates the global prevalence of high BP is 22% in adults, and prevalence is highest in low and middle income countries. Much of the global burden of high BP occurs in the Asia Pacific region, where almost 60% of the world's population reside; and, where affordability of treatment is vital to implementation.
UR - http://www.scopus.com/inward/record.url?scp=85013782217&partnerID=8YFLogxK
U2 - 10.1016/j.hlc.2017.02.001
DO - 10.1016/j.hlc.2017.02.001
M3 - Editorial
C2 - 28241926
AN - SCOPUS:85013782217
SN - 1443-9506
VL - 26
SP - 313
EP - 315
JO - Heart Lung and Circulation
JF - Heart Lung and Circulation
IS - 4
ER -